Thank you for the great engagement during our session on 20 February! Since there were so many insightful questions, we are launching a new feature on our website where you can find the full Q&A summary.
Thank you for the great engagement during our session on 20 February! Since there were so many insightful questions, we are launching a new feature on our website where you can find the full Q&A summary.
Biosecurity - Dr. Massab Umair
1. Question from Mr. Kittibhorn, Thailand
In preparing your presentation, which so effectively balanced local context with standard protocols, I was curious about the adaptation process. Approximately how much of the original content did you find neccessary to add or modify to ensure it resonated withthe local landscape?
Biosecurity - Dr. Massab Umair
2. Question from Ms. Nenita, Philippines:
In Pakistan, what specific categories of Pathogen data are eligible for sharing? Are there classification tiers that define sensitivity levels?
Biosecurity - Dr. Massab Umair
3. Question from Dr. Yoeke, Indonesia
As a NIH, do you have experience on distributing reference bacteria (ATCC Bacteria for example) that your regional lab might need for QC Procedure? if you do have, how do you manage for Biosecurity aspect?
Ethics in Laboratory - Dr. Amado
Questions form Mr. Kittibhorn, Thailand
as looking back to the original GLLP Desk, what are was the most 'overwhelming' setion for you to adapt, and what creative solution did you use to make it more digestible?
